/PRNewswire/ Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced.
New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatmentSINGAPORE - Media OutReach - 28 June 2023 – Biosyngen, an.
SHANGHAI, Feb. 7, 2023 /PRNewswire/ China-based Taimei Technology, a digital cooperationplatform for the life science industry, announced the opening of its new office in Singapore on February 1, 2023. The office, strategically located in one of the world's financial centres as well as one of APAC's economic and cultural centres, is expected to help accelerate the adoption of the company's innovative digital technologies for clinical research across the region and provide local customers with better services and experience with the support of local resources, while working with Taimei's partners to improve the application of digital technologies in regional clinical research and empower pharmaceutical innovations. Guests at the ribbon-cutting ceremony: Taimei Technology APAC BD head Sam Xu (first from left), National Healthcare Group (NHG) deputy CEO professor Benjamin Seet (second from left), Taimei Technology chairman and CEO Lu Zhao (middle), CSI Medical Research CE
Signs agreement with the Singapore Healthcare Clusters and the National Additive Manufacturing Innovation Cluster (NAMIC) to grow the 3D printed implant.